corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 2379

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: media release

Impactrx .
ImpactRx Announces the Launch of SampleLink™
ImpactRx 2005 Aug 24
http://www.impactrx.com/presscenter/releases/2005-0825.asp?on=headlines

Keywords:
SampleLink behaviour samples


Notes:

Ralph Faggotter’s Comments: Any doctor who is naiive enough to think that the handing over of free samples is a casual act of courtesy, should read this press release from a company which can carefully monitor their response to this seemingly insignificant gesture.
You may not know it, but that little box of sample pills can dramatically influence your prescribing patterns!


Full text:

ImpactRx Announces the Launch of SampleLinkâ„¢

~ New Jersey-Based Pharmaceutical Data Provider Launches First of Its Kind Product ~

Mount Laurel, N.J., August 24, 2005 – ImpactRx, Inc., innovative provider of quantitative insight on key influencers of physician behavior to the pharmaceutical industry, today announced the launch of SampleLinkâ„¢, a new tool specifically designed to provide actionable insights on prescription drug sampling.

Pharmaceutical promotional investment in product samples is second only to sales force costs, with retail value exceeding $10 billion annually. Yet, limited data are available to guide decisions on sample expenditures and deployment without embarking on extensive and lengthy analytical projects.

SampleLinkâ„¢ is designed to help clients develop and measure the impact of product samples at point of treatment. SampleLinkâ„¢ leverages ImpactRx’s unique data acquisition technology and breadth of longitudinal promotion and treatment data, with sample-specific productivity metrics to provide actionable insights into appropriate sample levels and effective sample deployment.

“Pharma’s ability to measure and track effectiveness of samples has been hampered by the almost total lack of sample data and easy to use analytical tools. As managed care and Medicare formularies become tighter, and pharma profitability challenges increase, it will be critical to understand how samples impact brand ROI,” said Nancy Lurker, CEO and President of ImpactRx… “We are extremely pleased to offer SampleLinkâ„¢ to provide insight into sample investment and deployment.”

About ImpactRx
Founded in October 2000, ImpactRx’s physician network is the source of unprecedented intelligence capability for assessing the impact of key pharmaceutical brand drivers on physician behavior and brand performance. Based in Mount Laurel , New Jersey , ImpactRx is a privately held company.

  1. # #

Contact Information:

Fred Nelson
Senior Vice President of Marketing and Public Relations
ImpactRx, Inc.
856-273-0221, ext. 142
fnelson@impactrx.com

Sara Kassabian
MCS Public Relations
(800) 477-9626
SaraK@mcspr.com

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909